Page 99 - NobleCon19revC2_Neat

GoHealth, Inc.

SELECTED FINANCIAL ITEMS GOCO

(in millions of USD)
CQ4 '22 CQ1 '23 CQ2 '23 CQ3 '23 LTM
Income Statement Key Items
Total Revenue 69.38 183.16 142.78 132.04 527.35
Gross Profit 48.75 137.70 106.36 96.05 388.85
Gross Margin 70% 75% 74% 73% 74%
EBIT (138.65) (5.75) (50.33) (37.98) (232.70)
EBIT Margin -200% -3% -35% -29% -44%
Net Income to Common Shareholders (150.74) (22.54) (70.23) (56.20) (299.71)
Net Margin -217% -12% -49% -43% -57%

Balance Sheet Key Items
Total Assets 1,659.29 1,543.45 1,482.25 1,437.41 1,437.41
Cash & Short Term Investments 16.46 32.33 25.36 26.39 26.39
% of Assets 1% 2% 2% 2% 2%
Current Assets -Total 414.56 375.46 368.10 346.32 346.32
% of Assets 25% 24% 25% 24% 24%
Total Liabilities 1,067.59 970.85 972.19 983.49 983.49
% of Assets 64% 63% 66% 68% 68%
Current Liabilities - Total 265.46 209.81 210.26 217.78 217.78
% of Assets 16% 14% 14% 15% 15%
Long Term Debt 504.81 490.21 496.22 496.97 496.97
% of Assets 30% 32% 33% 35% 35%
Total Equity 591.70 572.60 510.06 453.92 453.92
% of Assets 36% 37% 34% 32% 32%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (41.00) 20.48 10.86 6.50 (3.16)
Net Cash Flow - Investing (1.42) (2.23) (2.43) (3.43) (9.50)
Net Cash Flow - Financing (156.59) (2.40) (15.43) (2.19) (176.61)

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Nineteenth Annual Small & Microcap Investor Conference